Campbells has acted as the Cayman Islands and British Virgin Islands legal counsel for Beauty Farm Medical and Health Industry Inc. in connection with its approximately HK$783 million initial public offering and listing of its 230,581,068 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange, in which the Hong Kong Public Offering was very significantly oversubscribed 22 times.
O’Melveny & Myers, Grandall Law Firm (Shanghai) and Tian Yuan Law Firm acted as Hong Kong and PRC legal counsels, respectively, to Beauty Farm Medical and Health Industry Inc. Clifford Chance and Jingtian & Gongcheng acted as Hong Kong, U.S. and PRC legal counsels, respectively, to Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited (being the joint sponsors) and the underwriters (including Morgan Stanley Asia Limited, Haitong International Securities Company Limited, Huatai Financial Holdings (Hong Kong) Limited, CLSA Limited, ICBC International Securities Limited, Tiger Brokers (HK) Global Limited, Futu Securities International (Hong Kong) Limited and Valuable Capital Limited).
Beauty Farm Medical and Health Industry Inc. is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China, as measured by revenue in 2021. The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle. As of December 2022, the Company’s store network consisted of a total of 370 stores.
Partner Jenny Nip led the transaction with support from Chantelle Chan and Ben Tao.